Mindfulness-based intervention is helpful to younger breast cancer survivors
the ONA take:
Researchers from the University of California in Los Angeles randomized younger women (50 years and younger) with early stage breast cancer who had completed cancer treatment to a 6-week Mindful Awareness Practices (MAPS) intervention group or to a wait-list control group.
Outcomes were assessed via questionnaires participants completed before and after the intervention. The results demonstrated that the MAPS intervention led to reductions in perceived stress, depressive symptoms, proinflammatory gene expression, and inflammatory signaling.
Improvements were also seen in secondary outcomes related to fatigue, sleep disturbance, and vasomotor symptoms.
However, the 3-month follow-up assessment revealed the effects on psychological and behavioral measures were not maintained. The authors conclude that brief, mindfulness-based intervention has short-term efficacy for younger breast cancer survivors.
Younger women with early stage breast cancer who had completed cancer treatment to a 6-week MAPS.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|